Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia. | Korean J Urol;52(10): 681-6, 2011 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia.

Kim, Hyoung Woo; Moon, Dae Geun; Kim, Hyun Min; Hwang, Jong Ho; Kim, Soon Chan; Nam, Sam Geuk; Park, Jun Tag.

Affiliation

Kim HW; Department of Urology, Sahmyook Medical Center, Seoul, Korea.

Korean J Urol ; 52(10): 681-6, 2011 Oct.

Article in En | MEDLINE | ID: mdl-22087362

Key words

5-alpha-reductase inhibitors; Adrenergic alpha-antagonists; Combination; Drug therapy; Prostatic hyperplasia

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Language: En Journal: Korean J Urol Year: 2011 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Language: En Journal: Korean J Urol Year: 2011 Document type: Article